Literature DB >> 26993230

Vagus nerve stimulation mitigates intrinsic cardiac neuronal remodeling and cardiac hypertrophy induced by chronic pressure overload in guinea pig.

Eric Beaumont1, Gary L Wright1, Elizabeth M Southerland1, Ying Li1, Ray Chui2, Bruce H KenKnight3, J Andrew Armour4, Jeffrey L Ardell5.   

Abstract

Our objective was to determine whether chronic vagus nerve stimulation (VNS) mitigates pressure overload (PO)-induced remodeling of the cardioneural interface. Guinea pigs (n = 48) were randomized to right or left cervical vagus (RCV or LCV) implant. After 2 wk, chronic left ventricular PO was induced by partial (15-20%) aortic constriction. Of the 31 animals surviving PO induction, 10 were randomized to RCV VNS, 9 to LCV VNS, and 12 to sham VNS. VNS was delivered at 20 Hz and 1.14 ± 0.03 mA at a 22% duty cycle. VNS commenced 10 days after PO induction and was maintained for 40 days. Time-matched controls (n = 9) were evaluated concurrently. Echocardiograms were obtained before and 50 days after PO. At termination, intracellular current-clamp recordings of intrinsic cardiac (IC) neurons were studied in vitro to determine effects of therapy on soma characteristics. Ventricular cardiomyocyte sizes were assessed with histology along with immunoblot analysis of selected proteins in myocardial tissue extracts. In sham-treated animals, PO increased cardiac output (34%, P < 0.004), as well as systolic (114%, P < 0.04) and diastolic (49%, P < 0.002) left ventricular volumes, a hemodynamic response prevented by VNS. PO-induced enhancements of IC synaptic efficacy and muscarinic sensitivity of IC neurons were mitigated by chronic VNS. Increased myocyte size, which doubled in PO (P < 0.05), was mitigated by RCV. PO hypertrophic myocardium displayed decreased glycogen synthase (GS) protein levels and accumulation of the phosphorylated (inactive) form of GS. These PO-induced changes in GS were moderated by left VNS. Chronic VNS targets IC neurons accompanying PO to obtund associated adverse cardiomyocyte remodeling.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  autonomic regulation therapy; cardiac hypertrophy; guinea pig; intrinsic cardiac nervous system; pressure overload; vagus nerve stimulation

Mesh:

Substances:

Year:  2016        PMID: 26993230      PMCID: PMC4895835          DOI: 10.1152/ajpheart.00939.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  55 in total

Review 1.  Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival.

Authors:  Takashi Matsui; Tomohisa Nagoshi; Anthony Rosenzweig
Journal:  Cell Cycle       Date:  2003 May-Jun       Impact factor: 4.534

2.  Muscarinic and nicotinic ACh receptor activation differentially mobilize Ca2+ in rat intracardiac ganglion neurons.

Authors:  Friederike Beker; Martin Weber; Rainer H A Fink; David J Adams
Journal:  J Neurophysiol       Date:  2003-05-21       Impact factor: 2.714

Review 3.  Animal models of heart failure: a scientific statement from the American Heart Association.

Authors:  Steven R Houser; Kenneth B Margulies; Anne M Murphy; Francis G Spinale; Gary S Francis; Sumanth D Prabhu; Howard A Rockman; David A Kass; Jeffery D Molkentin; Mark A Sussman; Walter J Koch; Walter Koch
Journal:  Circ Res       Date:  2012-05-17       Impact factor: 17.367

4.  Neural control hierarchy of the heart has not evolved to deal with myocardial ischemia.

Authors:  G Kember; J A Armour; M Zamir
Journal:  Physiol Genomics       Date:  2013-05-21       Impact factor: 3.107

Review 5.  Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway.

Authors:  B Bonaz; C Picq; V Sinniger; J F Mayol; D Clarençon
Journal:  Neurogastroenterol Motil       Date:  2013-01-29       Impact factor: 3.598

Review 6.  The autonomic nervous system and heart failure.

Authors:  Viorel G Florea; Jay N Cohn
Journal:  Circ Res       Date:  2014-05-23       Impact factor: 17.367

7.  Parasympathetic inhibition of sympathetic effects on sinus rate in anesthetized dogs.

Authors:  Y Furukawa; Y Hoyano; S Chiba
Journal:  Am J Physiol       Date:  1996-07

8.  Interactions within the intrinsic cardiac nervous system contribute to chronotropic regulation.

Authors:  David C Randall; David R Brown; A Scott McGuirt; Gregory W Thompson; J Andrew Armour; Jeffrey L Ardell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-07-03       Impact factor: 3.619

9.  Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up.

Authors:  Marmar Vaseghi; Jean Gima; Christopher Kanaan; Olujimi A Ajijola; Alexander Marmureanu; Aman Mahajan; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2013-11-28       Impact factor: 6.343

10.  Differential sympathetic regulation of automatic, conductile, and contractile tissue in dog heart.

Authors:  J L Ardell; W C Randall; W J Cannon; D C Schmacht; E Tasdemiroglu
Journal:  Am J Physiol       Date:  1988-11
View more
  14 in total

1.  Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.

Authors:  Liping Zhou; Adrian Filiberti; Mary Beth Humphrey; Christian D Fleming; Benjamin J Scherlag; Sunny S Po; Stavros Stavrakis
Journal:  Exp Physiol       Date:  2018-11-29       Impact factor: 2.969

2.  Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans.

Authors:  Nicole Tran; Zain Asad; Khaled Elkholey; Benjamin J Scherlag; Sunny S Po; Stavros Stavrakis
Journal:  J Cardiovasc Transl Res       Date:  2018-12-17       Impact factor: 4.132

3.  Cervical vagus nerve stimulation augments spontaneous discharge in second- and higher-order sensory neurons in the rat nucleus of the solitary tract.

Authors:  Eric Beaumont; Regenia P Campbell; Michael C Andresen; Stephanie Scofield; Krishna Singh; Imad Libbus; Bruce H KenKnight; Logan Snyder; Nathan Cantrell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-05-05       Impact factor: 4.733

4.  Transcutaneous Vagus Nerve Stimulation Ameliorates the Phenotype of Heart Failure With Preserved Ejection Fraction Through Its Anti-Inflammatory Effects.

Authors:  Khaled Elkholey; Monika Niewiadomska; Lynsie Morris; Seabrook Whyte; Jeremy Houser; Mary Beth Humphrey; Stavros Stavrakis
Journal:  Circ Heart Fail       Date:  2022-07-07       Impact factor: 10.447

5.  Defining the neural fulcrum for chronic vagus nerve stimulation: implications for integrated cardiac control.

Authors:  Jeffrey L Ardell; Heath Nier; Matthew Hammer; E Marie Southerland; Christopher L Ardell; Eric Beaumont; Bruce H KenKnight; J Andrew Armour
Journal:  J Physiol       Date:  2017-09-30       Impact factor: 5.182

Review 6.  Calming the Nervous Heart: Autonomic Therapies in Heart Failure.

Authors:  Peter Hanna; Kalyanam Shivkumar; Jeffrey L Ardell
Journal:  Card Fail Rev       Date:  2018-08

7.  From drugs to devices and back again: chemical vagal nerve stimulation for the treatment of heart failure.

Authors:  Crystal M Ripplinger
Journal:  Cardiovasc Res       Date:  2017-09-01       Impact factor: 10.787

Review 8.  Neuroscientific therapies for atrial fibrillation.

Authors:  Peter Hanna; Eric Buch; Stavros Stavrakis; Christian Meyer; John D Tompkins; Jeffrey L Ardell; Kalyanam Shivkumar
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

Review 9.  Autonomic Modulation for Cardiovascular Disease.

Authors:  Joseph Hadaya; Jeffrey L Ardell
Journal:  Front Physiol       Date:  2020-12-22       Impact factor: 4.566

10.  Vagus nerve stimulation optimized cardiomyocyte phenotype, sarcomere organization and energy metabolism in infarcted heart through FoxO3A-VEGF signaling.

Authors:  Bin Luo; Yan Wu; Shu-Lin Liu; Xing-Yuan Li; Hong-Rui Zhu; Lei Zhang; Fei Zheng; Xiao-Yao Liu; Ling-Yun Guo; Lu Wang; Hong-Xian Song; Yan-Xia Lv; Zhong-Shan Cheng; Shi-You Chen; Jia-Ning Wang; Jun-Ming Tang
Journal:  Cell Death Dis       Date:  2020-11-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.